|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Zhang B, Beeghly-Fadiel A, Long J and
Zheng W: Genetic variants associated with breast-cancer risk:
Comprehensive research synopsis, meta-analysis, and epidemiological
evidence. Lancet Oncol. 12:477–488. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Rodgers RJ, Reid GD, Koch J, Deans R,
Ledger WL, Friedlander M, Gilchrist RB, Walters KA and Abbott JA:
The safety and efficacy of controlled ovarian hyperstimulation for
fertility preservation in women with early breast cancer: A
systematic review. Hum Reprod. 32:1033–1045. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chen W, Zheng R, Zeng H and Zhang S: The
updated incidences and mortalities of major cancers in China, 2011.
Chin J Cancer. 34:502–507. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Mulrane L, McGee SF, Gallagher WM and
O’Connor DP: miRNA dysregulation in breast cancer. Cancer Res.
73:6554–6562. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Sidiropoulos KG, Ding Q, Pampalakis G,
White NM, Boulos P, Sotiropoulou G and Yousef GM: KLK6-regulated
miRNA networks activate oncogenic pathways in breast cancer
subtypes. Mol Oncol. 10:993–1007. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Sorek R and Cossart P: Prokaryotic
transcriptomics: A new view on regulation, physiology and
pathogenicity. Nat Rev Genet. 11:9–16. 2010. View Article : Google Scholar
|
|
8
|
Wilusz JE and Sharp PA: Molecular biology.
A circuitous route to noncoding RNA. Science. 340:440–441. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhou B and Yu JW: A novel identified
circular RNA, circRNA_010567, promotes myocardial fibrosis via
suppressing miR-141 by targeting TGF-β1. Biochem Biophys Res
Commun. 487:769–775. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Xia W, Qiu M, Chen R, Wang S, Leng X, Wang
J, Xu Y, Hu J, Dong G, Xu PL, et al: Circular RNA has_circ_0067934
is upregulated in esophageal squamous cell carcinoma and promoted
proliferation. Sci Rep. 6:355762016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhang HD, Jiang LH, Sun DW, Hou JC and Ji
ZL: CircRNA: A novel type of biomarker for cancer. Breast Cancer.
Breast Cancer. 25:1–7. 2018. View Article : Google Scholar
|
|
12
|
Bartel DP: MicroRNAs: Target recognition
and regulatory functions. Cell. 136:215–233. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Qu S, Zhong Y, Shang R, Zhang X, Song W,
Kjems J and Li H: The emerging landscape of circular RNA in life
processes. RNA Biol. 14:992–999. 2017. View Article : Google Scholar :
|
|
14
|
Qu S, Yang X, Li X, Wang J, Gao Y, Shang
R, Sun W, Dou K and Li H: Circular RNA: A new star of noncoding
RNAs. Cancer Lett. 365:141–148. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhao Y, Alexandrov PN, Jaber V and Lukiw
WJ: Deficiency in the ubiquitin conjugating enzyme UBE2A in
Alzheimer’s disease (AD) is linked to deficits in a natural
circular miRNA-7 sponge (circRNA; ciRS-7). Genes (Basel).
7:1162016. View Article : Google Scholar
|
|
16
|
Han D, Li J, Wang H, Su X, Hou J, Gu Y,
Qian C, Lin Y, Liu X, Huang M, et al: Circular RNA circMTO1 acts as
the sponge of microRNA-9 to suppress hepatocellular carcinoma
progression. Hepatology. 66:1151–1164. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhong Z, Huang M, Lv M, He Y, Duan C,
Zhang L and Chen J: Circular RNA MYLK as a competing endogenous RNA
promotes bladder cancer progression through modulating VEGFA/VEGFR2
signaling pathway. Cancer Lett. 403:305–317. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zheng J, Deng J, Xiao M, Yang L, Zhang L,
You Y, Hu M, Li N, Wu H, Li W, et al: A sequence polymorphism in
miR-608 predicts recurrence after radiotherapy for nasopharyngeal
carcinoma. Cancer Res. 73:5151–5162. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
20
|
Su X, Wang H, Ge W, Yang M, Hou J, Chen T,
Li N and Cao X: An in vivo method to identify microRNA targets not
predicted by computation algorithms: p21 targeting by miR-92a in
cancer. Cancer Res. 75:2875–2885. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Li L, Zhang J, Xiong N, Li S, Chen Y, Yang
H, Wu C, Zeng H and Liu Y: Notch-1 signaling activates NF-κB in
human breast carcinoma MDA-MB-231 cells via PP2A-dependent AKT
pathway. Med Oncol. 33:332016. View Article : Google Scholar
|
|
22
|
Liu Y, Su C, Shan Y, Yang S and Ma G:
Targeting Notch1 inhibits invasion and angiogenesis of human breast
cancer cells via inhibition nuclear factor-κB signaling. Am J
Transl Res. 8:2681–2692. 2016.
|
|
23
|
Krell J, Stebbing J, Frampton AE,
Carissimi C, Harding V, De Giorgio A, Fulci V, Macino G, Colombo T
and Castellano L: The role of TP53 in miRNA loading onto AGO2 and
in remodelling the miRNA-mRNA interaction network. Lancet.
385(Suppl 1): S152015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Cuzick J, Sestak I and Thorat MA: Impact
of preventive therapy on the risk of breast cancer among women with
benign breast disease. Breast. 24(Suppl 2): S51–S55. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Sanger HL, Klotz G, Riesner D, Gross HJ
and Kleinschmidt AK: Viroids are single-stranded covalently closed
circular RNA molecules existing as highly base-paired rod-like
structures. Proc Natl Acad Sci USA. 73:3852–3856. 1976. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Jeck WR, Sorrentino JA, Wang K, Slevin MK,
Burd CE, Liu J, Marzluff WF and Sharpless NE: Circular RNAs are
abundant, conserved, and associated with ALU repeats. RNA.
19:141–157. 2013. View Article : Google Scholar :
|
|
27
|
Hansen TB, Jensen TI, Clausen BH, Bramsen
JB, Finsen B, Damgaard CK and Kjems J: Natural RNA circles function
as efficient microRNA sponges. Nature. 495:384–388. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Heneghan HM, Miller N and Kerin MJ: MiRNAs
as biomarkers and therapeutic targets in cancer. Curr Opin
Pharmacol. 10:543–550. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Liang HF, Zhang XZ, Liu BG, Jia GT and Li
WL: Circular RNA circ-ABCB10 promotes breast cancer proliferation
and progression through sponging miR-1271. Am J Cancer Res.
7:1566–1576. 2017.PubMed/NCBI
|
|
30
|
Fu L, Wu S, Yao T, Chen Q, Xie Y, Ying S,
Chen Z, Xiao B and Hu Y: Decreased expression of hsa_circ_0003570
in hepatocellular carcinoma and its clinical significance. J Clin
Lab Anal. May 11–2017.Epub ahead of print. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhang J, Liu H, Hou L, Wang G, Zhang R,
Huang Y, Chen X and Zhu J: Circular RNA_LARP4 inhibits cell
proliferation and invasion of gastric cancer by sponging miR-424-5p
and regulating LATS1 expression. Mol Cancer. 16:1512017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Memczak S, Jens M, Elefsinioti A, Torti F,
Krueger J, Rybak A, Maier L, Mackowiak SD, Gregersen LH, Munschauer
M, et al: Circular RNAs are a large class of animal RNAs with
regulatory potency. Nature. 495:333–338. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zhao ZJ and Shen J: Circular RNA
participates in the carcinogenesis and the malignant behavior of
cancer. RNA Biol. 14:514–521. 2017. View Article : Google Scholar :
|
|
34
|
Hansen TB, Wiklund ED, Bramsen JB,
Villadsen SB, Statham AL, Clark SJ and Kjems J: miRNA-dependent
gene silencing involving Ago2-mediated cleavage of a circular
antisense RNA. EMBO J. 30:4414–4422. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Du WW, Yang W, Liu E, Yang Z, Dhaliwal P
and Yang BB: Foxo3 circular RNA retards cell cycle progression via
forming ternary complexes with p21 and CDK2. Nucleic Acids Res.
44:2846–2858. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
He J, Xie Q, Xu H, Li J and Li Y: Circular
RNAs and cancer. Cancer Lett. 396:138–144. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Peng L, Yuan XQ and Li GC: The emerging
landscape of circular RNA ciRS-7 in cancer (Review). Oncol Rep.
33:2669–2674. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Hansen TB, Kjems J and Damgaard CK:
Circular RNA and miR-7 in cancer. Cancer Res. 73:5609–5612. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Tang YY, Zhao P, Zou TN, Duan JJ, Zhi R,
Yang SY, Yang DC and Wang XL: Circular RNA hsa_circ_0001982
promotes breast cancer cell carcinogenesis through decreasing
miR-143. DNA Cell Biol. 36:901–908. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Liang G, Liu Z, Tan L, Su AN, Jiang WG and
Gong C: HIF1α-associated circDENND4C promotes proliferation of
breast cancer cells in hypoxic environment. Anticancer Res.
37:4337–4343. 2017.PubMed/NCBI
|
|
41
|
Chen SP, Liu BX, Xu J, Pei XF, Liao YJ,
Yuan F and Zheng F: MiR-449a suppresses the epithelial-mesenchymal
transition and metastasis of hepatocellular carcinoma by multiple
targets. BMC Cancer. 15:7062015. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Li H, Li X, Ge X, Jia L, Zhang Z, Fang R,
Yang J, Liu J, Peng S, Zhou M, et al: MiR-34b-3 and miR-449a
inhibit malignant progression of nasopharyngeal carcinoma by
targeting lactate dehydrogenase A. Oncotarget. 7:54838–54851.
2016.PubMed/NCBI
|
|
43
|
You J, Zhang Y, Li Y, Fang N, Liu B, Zu L
and Zhou Q: MiR-449a suppresses cell invasion by inhibiting MAP2K1
in non-small cell lung cancer. Am J Cancer Res. 5:2730–2744.
2015.PubMed/NCBI
|
|
44
|
Shi W, Bruce J, Lee M, Yue S, Rowe M,
Pintilie M, Kogo R, Bissey PA, Fyles A, Yip KW, et al: MiR-449a
promotes breast cancer progression by targeting CRIP2. Oncotarget.
7:18906–18918. 2016.PubMed/NCBI
|
